|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash Flows from Operating Activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Impairment charges | |||||
| Provision for uncollectible accounts | |||||
| Deferred income taxes | |||||
| Share-based compensation expense | |||||
| Other | |||||
| Changes in assets and liabilities: | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Accounts payable | |||||
| Deferred revenue | |||||
| Other assets and liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash Flows from Investing Activities: | |||||
| Purchases of property and equipment | |||||
| Acquisitions of intangible assets | |||||
| Equity investments | |||||
| Acquisitions of businesses, net of cash acquired | |||||
| Proceeds from net investment hedges | |||||
| Net cash used by investing activities | |||||
| Cash Flows from Financing Activities: | |||||
| Borrowings (payments) on revolving credit facility, net | |||||
| Payments of senior notes | |||||
| Borrowings on term loan | |||||
| Payments of term loan | |||||
| Debt issuance costs | |||||
| Purchase of minority interest | |||||
| Repurchases of common stock | |||||
| Proceeds from exercises of stock options and employee stock purchase plans | |||||
| Payments of acquisition-related contingent consideration and holdbacks | |||||
| Shares withheld for statutory tax withholding payments on restricted stock | |||||
| Net cash used by financing activities | |||||
| Net effect of changes in exchange rates on cash | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
Loading...
